Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Psychol Med ; 53(15): 7062-7069, 2023 Nov.
Article in English | MEDLINE | ID: mdl-36951137

ABSTRACT

BACKGROUND: Cannabis use has been linked to psychotic disorders but this association has been primarily observed in the Global North. This study investigates patterns of cannabis use and associations with psychoses in three Global South (regions within Latin America, Asia, Africa and Oceania) settings. METHODS: Case-control study within the International Programme of Research on Psychotic Disorders (INTREPID) II conducted between May 2018 and September 2020. In each setting, we recruited over 200 individuals with an untreated psychosis and individually-matched controls (Kancheepuram India; Ibadan, Nigeria; northern Trinidad). Controls, with no past or current psychotic disorder, were individually-matched to cases by 5-year age group, sex and neighbourhood. Presence of psychotic disorder assessed using the Schedules for Clinical Assessment in Neuropsychiatry and cannabis exposure measured by the World Health Organisation Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). RESULTS: Cases reported higher lifetime and frequent cannabis use than controls in each setting. In Trinidad, cannabis use was associated with increased odds of psychotic disorder: lifetime cannabis use (adj. OR 1.58, 95% CI 0.99-2.53); frequent cannabis use (adj. OR 1.99, 95% CI 1.10-3.60); cannabis dependency (as measured by high ASSIST score) (adj. OR 4.70, 95% CI 1.77-12.47), early age of first use (adj. OR 1.83, 95% CI 1.03-3.27). Cannabis use in the other two settings was too rare to examine associations. CONCLUSIONS: In line with previous studies, we found associations between cannabis use and the occurrence and age of onset of psychoses in Trinidad. These findings have implications for strategies for prevention of psychosis.


Subject(s)
Cannabis , Marijuana Abuse , Psychotic Disorders , Humans , Case-Control Studies , Nigeria , Psychotic Disorders/epidemiology , Marijuana Abuse/epidemiology
2.
Psychol Med ; : 1-9, 2023 Jan 16.
Article in English | MEDLINE | ID: mdl-36645027

ABSTRACT

BACKGROUND: Extensive evidence indicates that rates of psychotic disorder are elevated in more urban compared with less urban areas, but this evidence largely originates from Northern Europe. It is unclear whether the same association holds globally. This study examined the association between urban residence and rates of psychotic disorder in catchment areas in India (Kancheepuram, Tamil Nadu), Nigeria (Ibadan, Oyo), and Northern Trinidad. METHODS: Comprehensive case detection systems were developed based on extensive pilot work to identify individuals aged 18-64 with previously untreated psychotic disorders residing in each catchment area (May 2018-April/May/July 2020). Area of residence and basic demographic details were collected for eligible cases. We compared rates of psychotic disorder in the more v. less urban administrative areas within each catchment area, based on all cases detected, and repeated these analyses while restricting to recent onset cases (<2 years/<5 years). RESULTS: We found evidence of higher overall rates of psychosis in more urban areas within the Trinidadian catchment area (IRR: 3.24, 95% CI 2.68-3.91), an inverse association in the Nigerian catchment area (IRR: 0.68, 95% CI 0.51-0.91) and no association in the Indian catchment area (IRR: 1.18, 95% CI 0.93-1.52). When restricting to recent onset cases, we found a modest positive association in the Indian catchment area. CONCLUSIONS: This study suggests that urbanicity is associated with higher rates of psychotic disorder in some but not all contexts outside of Northern Europe. Future studies should test candidate mechanisms that may underlie the associations observed, such as exposure to violence.

3.
BMJ Open ; 10(6): e039004, 2020 06 21.
Article in English | MEDLINE | ID: mdl-32565481

ABSTRACT

INTRODUCTION: There are few robust and directly comparable studies of the epidemiology of psychotic disorders in the Global South. INTREPID II is designed to investigate variations in untreated psychotic disorders in the Global South in (1) incidence and presentation (2) 2-year course and outcome, (3) help-seeking and impact, and (4) physical health. METHODS: INTREPID II is a programme of research incorporating incidence, case-control and cohort studies of psychoses in contiguous urban and rural areas in India, Nigeria and Trinidad. In each country, the target samples are 240 untreated cases with a psychotic disorder, 240 age-matched, sex-matched and neighbourhood-matched controls, and 240 relatives or caregivers. Participants will be followed, in the first instance, for 2 years. In each setting, we have developed and are employing comprehensive case-finding methods to ensure cohorts are representative of the target populations. Using methods developed during pilot work, extensive data are being collected at baseline and 2-year follow-up across several domains: clinical, social, help-seeking and impact, and biological. ETHICS AND DISSEMINATION: Informed consent is sought, and participants are free to withdraw from the study at any time. Participants are referred to mental health services if not already in contact with these and emergency treatment arranged where necessary. All data collected are confidential, except when a participant presents a serious risk to either themselves or others. This programme has been approved by ethical review boards at all participating centres. Findings will be disseminated through international conferences, publications in international journals, and through local events for key stakeholders.


Subject(s)
Mental Health Services , Psychotic Disorders , Research Design , Case-Control Studies , Follow-Up Studies , Help-Seeking Behavior , Humans , Incidence , India/epidemiology , Nigeria/epidemiology , Psychotic Disorders/epidemiology , Psychotic Disorders/therapy , Trinidad and Tobago/epidemiology
4.
Harv Rev Psychiatry ; 20(5): 247-58, 2012.
Article in English | MEDLINE | ID: mdl-23030213

ABSTRACT

The nineteenth century witnessed growing alarm among professionals and the public in the United States and Europe that the number of people in mental hospitals was rapidly rising. Whether this growth was caused by an increase in the incidence or prevalence of mental illness or by other factors has been debated for over 150 years. Those who believe that mental illness did increase attribute the change mainly to a rise in alcoholism, functional psychoses, syphilis, and disorders related to senescence. The hypothesis that functional psychoses increased has generated the most debate and is the focus of the present article. Those who believe that mental illness did not increase attribute the growth in mental hospital populations to various other factors that influence hospitalization. This article presents an historical overview of this long and complex debate. It is a balanced presentation of the arguments for and against a rise in mental illness. Original data from U.S. censuses and national reporting of mental hospital statistics are incorporated.


Subject(s)
Mental Disorders/history , History, 19th Century , History, 20th Century , Hospitals, Psychiatric/history , Hospitals, Psychiatric/statistics & numerical data , Humans , Incidence , Mental Disorders/epidemiology , Patient Admission/statistics & numerical data , Prevalence , Psychotic Disorders/epidemiology , Psychotic Disorders/history , Schizophrenia/epidemiology , Schizophrenia/history , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...